A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Status:
Recruiting
Trial end date:
2025-12-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether adding liver stereotactic ablative
radiotherapy/L-SABR to standard drug therapy is better than standard drug therapy alone for
people with metastatic non-small cell lung cancer/NSCLC.